The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|3|6|456-465

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.3, Iss.6, 2014-11, pp. : 456-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

By Tilling Lindsey   Townsend Sue   David Joel  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 55-62

Adis International

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Methotrexate improves survival in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

An update on methotrexate pharmacogenetics in rheumatoid arthritis

By Ranganathan Prabha  

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 439-451

Future Medicine

Access to resources Recommend Favorite

Biologic Battlefields: Changes in the US Markets for Rheumatoid Arthritis and Psoriatic Arthritis

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 3, 2004-01 ,pp. : 16-20

Adis International

Access to resources Recommend Favorite